| First Author | Ishiguro K | Year | 2000 |
| Journal | J Clin Invest | Volume | 106 |
| Issue | 7 | Pages | 873-8 |
| PubMed ID | 11018075 | Mgi Jnum | J:65092 |
| Mgi Id | MGI:1891769 | Doi | 10.1172/JCI10489 |
| Citation | Ishiguro K, et al. (2000) Complete antithrombin deficiency in mice results in embryonic lethality. J Clin Invest 106(7):873-8 |
| abstractText | Antithrombin is a plasma protease inhibitor that inhibits thrombin and contributes to the maintenance of blood fluidity. Using targeted gene disruption, we investigated the role of antithrombin in embryogenesis. Mating mice heterozygous for antithrombin gene (ATIII) disruption, ATIII(+/-), yielded the expected Mendelian distribution of genotypes until 14.5 gestational days (gd). However, approximately 70% of the ATIII(-/-) embryos at 15.5 gd and 100% at 16.5 gd had died and showed extensive subcutaneous hemorrhage. Histological examination of those embryos revealed extensive fibrin(ogen) deposition in the myocardium and liver, but not in the brain or lung. Furthermore, no apparent fibrin(ogen) deposition was detected in the extensive hemorrhagic region, suggesting that fibrinogen might be decreased due to consumptive coagulopathy and/or liver dysfunction. These findings suggest that antithrombin is essential for embryonic survival and that it plays an important role in regulation of blood coagulation in the myocardium and liver. |
